RenovoRx, Inc. (RNXT)
NASDAQ·Healthcare·Biotechnology
$1.05
-1.42%
Mkt Cap $29.33M
No analyst coverage available
We don't have analyst ratings or price target data for RenovoRx, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.